Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma
2021 · Nature · 519 citations
https://doi.org/10.1038/s41586-021-03704-y
Q
Qikai Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
8.1K
Citations
29
h-index
37
i10-index
Qikai Xu is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Immunotherapy and Immune Responses & CAR-T cell therapy research & Ubiquitin and proteasome pathways. The author has an h-index of 29, co-authored 49 publications.
ORCID: 0000-0003-0622-0998Papers by this author
worksComprehensive serological profiling of human populations using a synthetic human virome
2015 · Science · 487 citations
https://doi.org/10.1126/science.aaa0698
Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns
2018 · Cell · 235 citations
https://doi.org/10.1016/j.cell.2018.02.037
Comprehensive Identification of Host Modulators of HIV-1 Replication using Multiple Orthologous RNAi Reagents
2014 · Cell Reports · 58 citations
https://doi.org/10.1016/j.celrep.2014.09.031
TScan-II: A genome-scale platform for the de novo identification of CD4+ T cell epitopes
2023 · Cell · 46 citations
https://doi.org/10.1016/j.cell.2023.10.024
Cyberattack Resiliency Exercises in Radiation Oncology
2025 · International Journal of Radiation Oncology*Biology*Physics · 0 citations
https://doi.org/10.1016/j.ijrobp.2025.06.1132
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat